Organigram Global (NASDAQ:OGI – Get Free Report) and High Tide (NASDAQ:HITI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends.
Analyst Recommendations
This is a breakdown of current ratings for Organigram Global and High Tide, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Organigram Global | 1 | 0 | 0 | 0 | 1.00 |
| High Tide | 1 | 0 | 2 | 1 | 2.75 |
High Tide has a consensus target price of $6.13, indicating a potential upside of 144.02%. Given High Tide’s stronger consensus rating and higher possible upside, analysts plainly believe High Tide is more favorable than Organigram Global.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Organigram Global | 2.86% | -8.19% | -5.79% |
| High Tide | -1.66% | -6.50% | -3.84% |
Risk and Volatility
Organigram Global has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Comparatively, High Tide has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500.
Insider & Institutional Ownership
34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 4.5% of High Tide shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by insiders. Comparatively, 12.4% of High Tide shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Organigram Global and High Tide”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Organigram Global | $117.47 million | 1.92 | -$33.39 million | $0.05 | 33.40 |
| High Tide | $568.25 million | 0.39 | -$3.19 million | ($0.08) | -31.38 |
High Tide has higher revenue and earnings than Organigram Global. High Tide is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.
Summary
High Tide beats Organigram Global on 9 of the 15 factors compared between the two stocks.
About Organigram Global
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
About High Tide
High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. It operates licensed retail cannabis stores; and provides data analytics services. In addition, the company manufactures and distributes consumption accessories. Further, it sells its products through online sales via e-commerce platform. The company offers its products under the Daily High Club, DankStop, FABCBD, GC, Nuleaf, Smoke Cartel, and Blessed CBD brands. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.
Receive News & Ratings for Organigram Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram Global and related companies with MarketBeat.com's FREE daily email newsletter.
